2018
DOI: 10.1016/j.neulet.2017.11.049
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
108
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 142 publications
(112 citation statements)
references
References 12 publications
3
108
1
Order By: Relevance
“…A critical question has been how the AAV-PHP.B vectors cross the BBB and whether this mechanism can be translated to other species and, ultimately, humans. The enhanced CNS tropism of AAV-PHP.B and AAV-PHP.eB appears to extend to rats 14,15 , whereas studies testing AAV-PHP.B or related capsids in nonhuman primates (NHPs) have yielded differing outcomes [16][17][18] . Surprisingly, the enhanced CNS tropism of AAV-PHP.B 6,9,[12][13][14][15]19,20 is starkly absent in BALB/cJ mice 16 .…”
Section: Introductionmentioning
confidence: 99%
“…A critical question has been how the AAV-PHP.B vectors cross the BBB and whether this mechanism can be translated to other species and, ultimately, humans. The enhanced CNS tropism of AAV-PHP.B and AAV-PHP.eB appears to extend to rats 14,15 , whereas studies testing AAV-PHP.B or related capsids in nonhuman primates (NHPs) have yielded differing outcomes [16][17][18] . Surprisingly, the enhanced CNS tropism of AAV-PHP.B 6,9,[12][13][14][15]19,20 is starkly absent in BALB/cJ mice 16 .…”
Section: Introductionmentioning
confidence: 99%
“…Viral labeling approaches have shown the most promise; however, clear limitations exist since most enhancer elements are not defined and viral vectors have limited capacity to include large gene elements 40 . Moreover, achieving systemic coverage of the entire brain with viral labeling also remains challenging 57 . We anticipate that the scalability and flexibility of eFLASH will aid organ-wide phenotyping efforts on such model animals.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, it is desirable to screen AAV capsid libraries in cells of human origin rather than in murine or other animal models. This has been clearly evidenced by a highly neurotropic AAV variant (AAV-PHP.B) that had recently been discovered through an in vivo library screen in mice (Deverman et al, 2016) and unfortunately was recently found to exhibit this enhanced tropism in mice only (Hordeaux et al, 2018;Matsuzaki et al, 2018). However, for the purpose of preclinical testing, it is desirable to develop capsids that can transduce murine cells in addition to human cells as this can accelerate the translation of different gene therapy approaches to the clinic.…”
Section: Discussionmentioning
confidence: 99%